Table 1 Characteristics of included and not included women living with HIV (WLWH) in Denmark from the Danish HIV Cohort Study (DHCS)
WLWH included in the study | WLWH not included in the study | p-value | |
|---|---|---|---|
Number of individuals | 334 (24.0) | 1,058 (76.0) | NA |
Follow-up (years), median (IQR) | 11.3 (5.9-16.9) | 10.6 (5.5-15.9) | 0.097 |
Follow-up time, total (person-years) | 3,853 | 11,183 | NA |
Age at inclusion (years), median (IQR) | 42.5 (36.8-48.3) | 42.0 (35.5-48.2) | 0.22 |
Race, n(%) | |||
White | 141 (42.6) | 398 (39.5) | 0.041a |
Asian | 44 (13.3) | 114 (11.3) | |
Black | 143 (43.2) | 461 (45.7) | |
Other | 3 (0.9) | 35 (3.5) | |
(missing) | (3) | (50) | |
Place of HIV transmission, n(%) | |||
Denmark | 114 (37.8) | 326 (34.8) | 0.11 |
Europe + US | 27 (8.9) | 77 (8.2) | |
Africa | 128 (42.4) | 416 (44.4) | |
Asia | 33 (10.9) | 101 (10.8) | |
Other | 0 (0) | 17 (1.8) | |
(missing) | (32) | (121) | |
Mode of transmission, n(%) | |||
Heterosexual | 294 (91.6) | 799 (83.6) | 0.0015 |
IDU | 16 (5.0) | 106 (11.1) | |
Other | 11 (3.4) | 51 (5.3) | |
(missing) | (13) | (102) | |
Age at sexual debut (years), | |||
mean (range) | 17.3 (6–37) | -b | NA |
Lifetime sexual partners, n(%) | |||
< 5 | 99 (29.6) | -b | NA |
5–14 | 135 (40.4) | ||
15–25 | 45 (13.5) | ||
> 25 | 53 (15.9) | ||
Does not wish to respond | 2 (0.6) | ||
(missing) | (0) | ||
CD4 count at inclusion (cells/μL), n(%) | |||
< 200 | 12 (3.9) | 79 (9.1) | 0.012 |
200–350 | 51 (16.5) | 138 (15.9) | |
> 350 | 247 (79.7) | 650 (75.0) | |
(missing) | (24) | (191) | |
HAART at inclusion, n(%) | |||
Yes | 317 (94.9) | 866 (81.8) | <0.0001 |
No | 17 (5.1) | 192 (18.2) | |
(missing) | (0) | (0) | |
On HAART with | |||
HIV RNA < 40 copies/mL, n(%) | |||
Yes | 250 (83.6) | 576 (75.5) | 0.0042 |
No | 49 (16.4) | 187 (24.5) | |
(missing) | (18) | (103) | |
Cervical cytology within the past 1 year, n(%)c | |||
Yes | 124 (37.1) | 225 (21.3) | <0.0001 |
No | 210 (62.9) | 833 (78.7) | |
(missing) | (0) | (0) | |
Cervical cytology within the past 3/5 years – depending on age for women age 23–65 years, n(%)d | |||
Yes | 227 (67.7) | 429 (40.6) | <0.0001 |
No | 96 (28.7) | 555 (52.5) | |
Outside target age group | 11 (3.3) | 74 (7.0) | |
(missing) | (0) | (0) | |
Last cytology result, n(%) | |||
Normal | 242 (72.5) | 513 (48.5) | <0.0001 |
Abnormal | 9 (2.7) | 21 (2.0) | |
No prior cytology obtained | 83 (24.9) | 524 (49.5) | |
HPV vaccination prior to inclusion, n(%) | |||
Yes (4-valent HPV vaccine) | 4 (1.2) | -b | NA |
Yes (2-valent HPV vaccine) | 0 (0) | ||
Yes (do not know name of vaccine) | 1 (0.3) | ||
No | 329 (98.5) | ||
(missing) | (0) | ||